The addition of radiofrequency ablation for patients receiving sorafenib: new evidence for a new standard?

por Lock, Michael, Meyers, Brandon M., Mujoomdar, Amol
Publicado 2021

Percutaneous ultrasound gastrostomy (PUG): first prospective clinical trial

por Accorsi, Fabio, Chung, Jonathan, Mujoomdar, Amol, Wiseman, Daniele, Kribs, Stewart, Cool, Derek W.
Publicado 2021

Proximal splenic artery embolization using a vascular plug in grade IV or V splenic trauma – a single centre 11-year experience

por Xu, Samuel S., Eng, Kevin, Accorsi, Fabio, Cool, Derek W., Wiseman, Daniele, Mujoomdar, Amol, Cardarelli-Leite, Leandro
Publicado 2023

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population

por Wells, Malcolm M., Li, Zhe, Addeman, Bryan, McKenzie, Charles A., Mujoomdar, Amol, Beaton, Melanie, Bird, Jeffery
Publicado 2016

Efficacy of (177)Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study

por Sistani, Golmehr, Sutherland, Duncan E. K., Mujoomdar, Amol, Wiseman, Daniele P., Khatami, Alireza, Tsvetkova, Elena, Reid, Robert H., Laidley, David T.
Publicado 2020

Overall Impact of the COVID-19 Pandemic on Interventional Radiology Services: A Canadian Perspective

por Patel, Neeral R., El-Karim, Ghassan Awad, Mujoomdar, Amol, Mafeld, Sebastian, Jaberi, Arash, Kachura, John R., Tan, Kong Teng, Oreopoulos, George D.
Publicado 2020

Survival predictors of (177)Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

por Swiha, Mina M., Sutherland, Duncan E. K., Sistani, Golmehr, Khatami, Alireza, Abazid, Rami M., Mujoomdar, Amol, Wiseman, Daniele P., Romsa, Jonathan G., Reid, Robert H., Laidley, David T.
Publicado 2021